RecruitingNot ApplicableNCT06883266

Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD

Transcranial Direct Current Stimulation (tDCS) to Improve Motor Function and Motor Fatigue in Parkinson's Patients

Sponsor

Sanford Health

Enrollment

64 participants

Start Date

Nov 11, 2024

Study Type

INTERVENTIONAL

Conditions

Parkinsons Disease (PD)

Summary

The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is testing whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) — which uses a mild electrical current applied to the scalp — can improve movement and reduce fatigue in people with Parkinson's disease. **You may be eligible if...** - You have been clinically diagnosed with Parkinson's disease, showing at least two of these: tremor, muscle stiffness, slowness of movement, or balance problems - You are able to give informed consent **You may NOT be eligible if...** - You have significant cognitive decline (low score on memory/cognition test) - You have a deep brain stimulation (DBS) device implanted - You have been diagnosed with psychosis, multiple sclerosis, stroke, COPD, or heart failure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEtranscranial direct current stimulation (tDCS)

2 mA will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex.

DEVICESham (No Treatment)

For 30 seconds, the patient will experience a ramp up of the stimulation, after which point no stimulation will be transmitted for the remainder of the session. This will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex